Q2 2024 Glenmark Life Sciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome the Glenmark Life Sciences Q2 FY24 earnings conference. (Operator Instructions) Please note that conference is being recorded.
I now hand the conference over to Ms. Soumi Rao, General Manager, Corporate Communications. Thank you, and over to you, ma'am.
Good evening, everyone. I welcome you all to the earnings conference call of Glenmark Life Sciences Limited for the quarter ended September 30, 2023. From Glenmark Life Sciences we have with us Dr. Yasir Rawjee, our MD and CEO; and Mr. Tushar Mistry, our CFO. Our Board has approved the results for the quarter ended September 30, 2023. We released the same to the stock exchanges and updated on our website. Please note that the recording and the transcript of this call will be available on the website of the company.
Now, I'd like to draw your attention to the fact that some of the information shared as part of this call, especially information with respect to our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |